-
New tool being developed by the University of Waterloo to help identify false health claims.
Medical Mythbusting Commentary for August 29, 2024 Source:‘Life-or-death’ issue: How one tool is identifying false health claims on social media Reference:A Big Data ecosystem for evaluating health misinformation on social media
-
AI stethoscope demonstrates ‘the power as well as the risk’ of emerging technology
Medical Mythbusting Commentary for June 13, 2024 Source:AI stethoscope demonstrates ‘the power as well as the risk’ of emerging technology
-
Will AI replace doctors who read X-rays, or make them better? The latter is more likely. Too many nuances to diagnostics and radiologists do much more than interpret imaging studies.
Medical Mythbusting Commentary for May 15, 2024 Source:Will AI replace doctors who read X-rays, or make them better?
-
Neuralink now accepting Canadian patients
Medical Mythbusting Commentary for April 2, 2024 Source:Elon Musk’s Neuralink now accepting Canadian patients
-
FB1006: AI-discovered drug advances to clinical trials for ALS treatment
Medical Mythbusting Commentary for February 29, 2024 Source:FB1006: AI-discovered drug advances to clinical trials for ALS treatment
-
FDA approves AI scanner that increases the physician’s accuracy in identifying skin cancers like basal and squamous cell carcinoma and melanoma.
Medical Mythbusting Commentary for January 19, 2024 Source:FDA Approves AI Device That Helps Spot Skin Cancer
-
AI recognition of changes in sugar molecules within saliva may help detect early stage cancer within the next five years according to researchers.
Medical Mythbusting Commentary for December 14, 2023 Source:Here’s how a ‘little saliva’ could detect Stage 1 cancer Reference:Decoding glycomics with a suite of methods for differential expression analysis
-
AI shows major promise in breast cancer detection, new studies suggest
Medical Mythbusting Commentary for September 12, 2023 Source:AI shows major promise in breast cancer detection, new studies suggest Reference:Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study
-
AI brain implant helps woman speak for the 1st time in 18 years after suffering a stoke when she was 30 that resulted in locked-in syndrome
Medical Mythbusting Commentary for August 28, 2023 [display_podcast] Source:AI brain implant helps Sask. woman speak for the 1st time in 18 years